In-Vivo Comparison of Different Impression Methods in Complete Edentulous Upper Jaw

May 1, 2024 updated by: Sinem Kahya Karaca, Hacettepe University

In this study, it was aimed to compare the impressions taken with different impression techniques for the production of tissue-supported complete dentures from individuals with complete edentulous upper jaws. For this purpose, 15 individuals with complete edentulism in the upper jaw were asked to participate in the study. In addition to agreeing to participate in the study after reading the consent form, these individuals should have been using tissue-supported complete dentures in the upper jaw for at least 3 months. They should also have healthy mucosa without local factors such as tissue hyperplasia, atrophic crests, allergic reaction, epulis fissuratum. A total of five final impressions will then be taken from these individuals in two sessions. Two of these impressions will be obtained with the traditional method and three with the digital method. The traditional impression group will include one-step (ALG) and two-step (ZOE) impression techniques. The digital impression group will include the digital impression taken when the artificial intelligence is deactivated (A.I OFF), the digital impression taken when the artificial intelligence is activated (A.I ON) and the modified technique (MOD). In the first appointment, the first impressions will be taken for the traditional and digital groups. Intraoral exclusion and isolation will be provided before the digital first impression. With the A.I mode of the intraoral scanner (TRIOS4; 3Shape A/S, Copenhagen, Denmark) deactivated, scanning will be performed in accordance with the scanning protocol recommended by the company. A metal stock tray suitable for the dental arch will then be selected for the preliminary impression of the traditional impression group. The impression will be taken in one step with irreversible hydrocolloid impression material. The impression will be digitized with the same intraoral scanner within the first 10 minutes after impression taking. Both impressions will be digitally transferred to the dental laboratory as stl data. Using computer aided design (CAD) software (Exocad DentalCAD 2.4 Plovdiv), an individual tray will be designed for the ZOE impression in the traditional group and a pedestal for the MOD impression in the digital impression group. The designs will be transferred to the computer aided manufacturing (CAM) unit and produced with a 3D printer using dental resin. The occlusal-rim (OR) will be prepared by adding wax on the base.

In the second appointment, the cheek and lips will be excluded in the same way before scanning. For A.I OFF and A.I ON, recordings will be taken when the artificial intelligence is deactivated and activated, respectively. Then, occlusal vertical dimension, intermaxillary relationship and aesthetic parameters will be determined with OR before scanning for the MOD group. Reference areas will be created on the buccal and palatinal walls to facilitate scanning of the OR. To avoid retention problems during scanning, a silicone-based impression material with a fluid consistency will be applied to the tissue surface of the OR and placed in the mouth. Scanning will be performed according to the protocol proposed by Lo Russo et al. For the traditional impression group, the ALG impression will be taken with a metal stock tray using irreversible hydrocolloid impression material in a single step. The impression will be digitized with an intraoral scanner within ten minutes of completion. Then, the edges of the individual tray for ZOE will be shaped with impression compound to ensure peripheral closure. The impression will be completed with zinc-oxide eugenol impression material. The impression will be digitized. These measurements will then be compared using a reverse-engineering program (Geomagic design X version 2016.1.0, 3D Systems Inc. Rock Hill, SC). Before the comparison, in the same program, the parts to be evaluated on the ZOE in the conventional group and A.I OFF in the digital group will be divided into regions. These areas will be divided into four sections as right and left vestibular region, postdam area, hard palate region, except for the A.I OFF-MOD comparison group. In the A.I OFF-MOD comparison group, it will include the right and left initial areas, including the areas where scanning starts in the second scan of the MOD method. In addition, all measurements will be compared in terms of the whole surface and all measurement boundaries including the whole measurement surface as one. The comparison groups are ZOE-ALG, ZOE-A.I OFF, A.I OFF-A.I ON, A.I OFF-MOD. The measurements in the comparison groups will be overlapped first with the initial alignment and then with the best fit alignment algorithm. All sections will be evaluated individually with the "3D compare" feature and the amount of deviation in the areas to be evaluated will be determined.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Altındağ
      • Ankara, Altındağ, Turkey
        • Hacettepe University Faculty of Dentistry

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Volunteers who had been using maxillary complete denture for at least 3 months
  • Volunteers were clinically evaluated for healthy oral mucosa

Exclusion Criteria:

  • Volunteers who had general health problems
  • Volunteers who had of tissue hyperplasia, labile alveolar crest, allergic reaction to the prosthesis, percussion or mucosal irritation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Irreversible Hydrocolloid
Final impression taken with irreversible hydrocolloid impression material and stock tray in single step.
Final impressions of edentulous maxilla separated in two groups. In physical impression group stock and individual trays and physical impression materials used.
Other: Zinc Oxide Eugenol
Final impression taken with zinc oxide eugenol impression material and individual tray in two steps.
Final impressions of edentulous maxilla separated in two groups. In physical impression group stock and individual trays and physical impression materials used.
Other: Intraoral Scanner - Artificial Intelligence Off
Final impression taken with intraoral scanner in artificial intelligence mode deactivated in single step.
Final impressions of edentulous maxilla separated in two groups. In physical impression group stock and individual trays and physical impression materials used.
Other: Intraoral Scanner - Artificial Intelligence On
Final impression taken with intraoral scanner in artificial intelligence mode activated in single step.
Final impressions of edentulous maxilla separated in two groups. In physical impression group stock and individual trays and physical impression materials used.
Other: Intraoral Scanner - Modified
Final impression taken with intraoral scanner in two steps using occlusal rim.
Final impressions of edentulous maxilla separated in two groups. In physical impression group stock and individual trays and physical impression materials used.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Three Dimensional Difference Between Irreversible Hydrocolloid and Zinc Oxide Eugenol Impressions
Time Frame: Through study completion, an average of 6 months
Evaluation of the three-dimensional difference between two impressions using a reverse-engineering program and quantification of the deviation
Through study completion, an average of 6 months
Three Dimensional Difference Between Zinc Oxide Eugenol and Intraoral Scanner AI Off Impressions
Time Frame: Through study completion, an average of 6 months
Evaluation of the three-dimensional difference between two impressions using a reverse-engineering program and quantification of the deviation
Through study completion, an average of 6 months
Three Dimensional Difference Between Intraoral Scanner AI Off and AI On Impressions
Time Frame: Through study completion, an average of 6 months
Evaluation of the three-dimensional difference between two impressions using a reverse-engineering program and quantification of the deviation
Through study completion, an average of 6 months
Three Dimensional Difference Between Intraoral Scanner AI Off and Modified Impressions
Time Frame: Through study completion, an average of 6 months
Evaluation of the three-dimensional difference between two impressions using a reverse-engineering program and quantification of the deviation
Through study completion, an average of 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sinem Kahya Karaca, Hacettepe University, Faculty of Dentistry
  • Study Director: Kıvanç Akça, Prof. Dr., Hacettepe University, Faculty of Dentistry

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 30, 2022

Primary Completion (Actual)

December 30, 2023

Study Completion (Actual)

March 27, 2024

Study Registration Dates

First Submitted

April 29, 2024

First Submitted That Met QC Criteria

May 1, 2024

First Posted (Actual)

May 6, 2024

Study Record Updates

Last Update Posted (Actual)

May 6, 2024

Last Update Submitted That Met QC Criteria

May 1, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe